KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Work In Process: 2011-2020

Historic Work In Process for Emergent BioSolutions (EBS) over the last 8 years, with Mar 2020 value amounting to $114.2 million.

  • Emergent BioSolutions' Work In Process was N/A to $114.2 million in Q1 2020 from the same period last year, while for Mar 2020 it was $114.2 million, marking a year-over-year change of. This contributed to the annual value of $89.7 million for FY2019, which is 13.08% down from last year.
  • According to the latest figures from Q1 2020, Emergent BioSolutions' Work In Process is $114.2 million, which was up 27.31% from $89.7 million recorded in Q4 2019.
  • In the past 5 years, Emergent BioSolutions' Work In Process registered a high of $119.1 million during Q2 2019, and its lowest value of $14.8 million during Q3 2017.
  • For the 3-year period, Emergent BioSolutions' Work In Process averaged around $94.9 million, with its median value being $96.5 million (2018).
  • Per our database at Business Quant, Emergent BioSolutions' Work In Process crashed by 39.59% in 2017 and then soared by 338.72% in 2018.
  • Emergent BioSolutions' Work In Process (Quarterly) stood at $19.8 million in 2016, then soared by 286.46% to $76.6 million in 2017, then surged by 34.73% to $103.2 million in 2018, then dropped by 13.08% to $89.7 million in 2019, then reached $114.2 million in 2020.
  • Its Work In Process was $114.2 million in Q1 2020, compared to $89.7 million in Q4 2019 and $106.6 million in Q3 2019.